- 4-Week # shares sold: 6,500
- 12-Week # shares sold: 22,000
- 24-Week # shares sold: 27,566
Shares of this oil refiner could be poised for gains in the months ahead, thanks to pressure from an activist investor.
Horizon Pharma is a 'giant headache,' says Jim Cramer; Abbot Labs is OK long term.
Holiday-shortened week holds a feast of earnings reports, says Jim Cramer.